Skip to content

Depression: all studies

Page 753 of 1,034: studies 7,521 to 7,530 of 10,336, newest first. Back to the depression overview

Research

Perceived Stress, Resilience, and Wellbeing in Seasoned Isha Yoga Practitioners Compared to Matched Controls During the COVID-19 Pandemic

Frontiers in Public Health July 29, 2022 Preeti Upadhyay, Shilpa Narayanan, Tanvi Khera et al.

BackgroundYoga practices, including breathing, meditation, and posture protocols (asanas), have been shown to facilitate physical and mental wellbeing.MethodsSeasoned yoga practitioners were recruited from the Isha Foundation. Recruitment of the comparison group was achieved using snowball sampling and were not yoga practitioners. Participants in the non-yoga group were randomized to a 3-min...

Research in Mindfulness Interventions for Patients With Fibromyalgia: A Critical Review.

Frontiers in Integrative Neuroscience July 28, 2022 Salomé Leça, Isaura Tavares 26 citations

Fibromyalgia is one of the most common causes of widespread chronic pain. It has a huge impact on the quality of life, namely because it appears earlier in life than most of the chronic pain conditions. Furthermore, emotional-cognitive distress factors, such as depression and anxiety, are a common feature in patients with fibromyalgia. The neurobiological mechanisms underlying fibromyalgia...

Mindfulness in Schools: Evidence on the Impacts of School-Based Mindfulness Programs on Student Outcomes in P–12 Educational Settings

July 27, 2022 Robert W Roeser, Brian M. Galla, Rebecca N. Baelen 57 citations preprint

This Research Brief was developed for the Robert Wood Johnson Foundation. The number of school-based mindfulness programs (SBMPs) for students has been increasing over the last fifteen years. They’ve been developed for students from pre- kindergarten through high school (P–12 settings). While the reach of SBMPs is substantial, their introduction has outpaced research on their effectiveness...

Nature-Based Meditation, Rumination and Mental Wellbeing

International Journal of Environmental Research and Public Health July 26, 2022 Matthew Owens, Hannah L. I. Bunce

Novel approaches for children and young people (CYP) in the prevention and intervention of mental illness are needed and nature-based interventions (NBI) may be clinically useful. This proof-of-principle study tested the effects of a novel brief nature-based meditation on rumination, depressive symptoms and wellbeing in young people. Sixty-eight university students were randomised to one of...

Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents

Scientific Reports July 26, 2022 Caroline T. Golden, Paul Chadderton 45 citations

Abstract Psilocybin is a hallucinogenic compound that is showing promise in the ability to treat neurological conditions such as depression and post-traumatic stress disorder. There have been several investigations into the neural correlates of psilocybin administration using non-invasive methods, however, there has yet to be an invasive study of the mechanism of action in awake rodents. Using...

DOI: 10.1038/s41598-022-16325-w (opens in new tab) Full text (opens in new tab) Psilocybin Anterior cingulate cortex Cortex anatomy Hallucinogen +3

Examining the Acceptability and Feasibility of the Compassionate Mindful Resilience (CMR) Programme in Adult Patients with Chronic Kidney Disease: The COSMIC Study Protocol.

Healthcare July 25, 2022 Anna Wilson, Clare Mckeaveney, Claire Carswell et al.

Kidney disease is often progressive, and patients experience diminished health-related quality of life. In addition, the impact of the coronavirus (COVID-19) pandemic, and its associated restrictions, has brought many additional burdens. It is therefore essential that effective and affordable systems are explored to improve the psychological health of this group that can be delivered safely...

COVID-19 nightmare response and stress: A new Mexico sample based survey.

Sleep Medicine July 20, 2022 Tim CampBell, Ariel Hurwitz, Robyn Bartel et al.

Studies conducted during the COVID-19 Pandemic have reported increased rates of mental illnesses including depression, anxiety, and post-traumatic stress disorder (PTSD) [1]. A common symptom of mental illness is change in Rapid Eye Movement (REM) sleep, the phase of sleep associated with dreaming and nightmares. The COVID-19 pandemic offers a unique opportunity to evaluate the effects of...

DOI: 10.1016/j.sleep.2022.07.008 (opens in new tab) Full text (opens in new tab) Humans Dreams Stress disorders, post-traumatic New mexico +2

Exploring the Nexus Between Mindfulness, Gratitude, and Wellbeing Among Youth With the Mediating Role of Hopefulness: A South Asian Perspective.

Frontiers in Psychology July 19, 2022 Salima Barkat Ali, Munawar Javed Ahmad, Iqra Ramzan et al.

This study investigates the relationship between mindfulness, gratitude, and psychological wellbeing of young individuals in Pakistan with the potential role of hopefulness as a mediator between mindfulness, gratitude, and wellbeing. Data were collected from young individuals (18-40 years old) from Pakistan. A total sample of 500 participants was collected by employing the online survey...

Effects of group mindfulness-based cognitive therapy and group cognitive behavioural therapy on symptomatic generalized anxiety disorder: a randomized controlled noninferiority trial

BMC Psychiatry July 19, 2022 Si-si Jiang, Xuefeng Liu, Nan Han et al.

Background Mindfulness-based cognitive therapy (MBCT) is a promising alternative treatment for generalized anxiety disorder (GAD). The objective of this study was to examine whether the efficacy of group MBCT adapted for treating GAD (MBCT-A) was noninferior to group cognitive behavioural therapy (CBT) designed to treat GAD (CBT-A), which was considered one of first-line treatments for GAD...

Magic Mushrooms – an exploratory look at how mental health professionals feel and think about Psilocybin

Psychiatry Research July 16, 2022 Thomas D Meyer, Priel Meir, Claudia Lex et al. 23 citations

Psilocybin recently received breakthrough status by the FDA for its use in treatment of depression. We therefore investigated mental health professionals' (MHPs) opinions on Psilocybin (n = 155). Overall, attitudes were neutral but self-rated knowledge of Psilocybin was low. The term used in the survey, 'Psilocybin' or 'Magic Mushrooms', did not significantly affect their responses. Some...

DOI: 10.1016/j.psychres.2022.114727 (opens in new tab) Psilocybin Hallucinogen Mental health Exploratory research +2